Sjeng Horbach

Title: Sjeng Horbach: Innovator in Antibody Development

Introduction

Sjeng Horbach is a notable inventor based in Oss, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic applications. With a total of three patents to his name, Horbach's work is focused on advancing cancer therapy through innovative solutions.

Latest Patents

Horbach's latest patents revolve around antibodies that bind to 5T4, including bispecific antibodies that target both 5T4 and CD3. These inventions provide pharmaceutical compositions that utilize these antibodies for therapeutic and diagnostic procedures, especially in the context of cancer treatment. His research aims to enhance the efficacy of cancer therapies, offering new hope for patients.

Career Highlights

Sjeng Horbach is currently associated with Genmab AS, a leading biotechnology company known for its focus on developing differentiated antibody therapeutics for the treatment of cancer. His role at Genmab has allowed him to contribute to groundbreaking research and development in the field of immunotherapy.

Collaborations

Throughout his career, Horbach has collaborated with esteemed colleagues, including David Satijn and Esther C W Breij. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pursuit of advancing cancer therapies.

Conclusion

Sjeng Horbach's work in antibody development exemplifies the impact of innovative research in the fight against cancer. His contributions through patents and collaborations highlight the importance of continued advancements in biotechnology.